David Parkinson, MD

Dr. Parkinson has served as President and Chief Executive Officer of ESSA Pharma Inc. since January 2016, and as a Director of the company since June 2015. Prior to joining ESSA he had been a Venture Partner at New Enterprise Associates, Inc. From 2007 until 2012, Dr. Parkinson served as President and CEO of Nodality, […]

Eileen O’Reilly, MD

Dr. Eileen M. O’Reilly holds the Winthrop Rockefeller Endowed Chair in Medical Oncology at Memorial Sloan Kettering (MSK). She serves as the Section Head for Hepatopancreaticobiliary/ Neuroendocrine Cancers, Gastrointestinal Oncology Service, Co-Director for Medical Initiatives at the David M. Rubenstein Center for Pancreatic Cancer and is an Attending Physician and Member at MSK and Professor […]

Patricia LoRusso, DO

Dr. Patricia LoRusso has been a practicing academic medical oncologist performing clinical/translational research in early phase clinical trials for 30 years, spending the first 25 years at Wayne State University/Karmanos Cancer Institute in Detroit, MI and transitioning to Yale University/Yale Cancer Center in 2014. Both institutions have NCI comprehensive designation status. She has had continuous […]

Manuel Hidalgo, MD, PhD

Manuel Hidalgo, M.D., Ph.D., a leading physician-scientist specializing in pancreatic cancer and drug development, is the Chief of the Division of Hematology and Medical Oncology and E. Hugh Luckey Distinguished Professor of Medicine at Weill Cornell Medicine/New York-Presbyterian Hospital. Dr Hidalgo is also Associate Director for Clinical Services at the Sandra and Edward Meyer Cancer […]

Wayne Klohs, PhD

Dr. Klohs is an R&D executive and scientist with thirty-five years of experience in the pharmaceutical industry with increasing levels of responsibility held in positions across the drug development and discovery spectrum. He is currently a consultant for several companies including the SAB for Aeglea Therapeutics, SAB and DOB for MAIA Biotechnology, Chairman of the […]